Priti Prasanna Maity | Tissue Engineering | Best Researcher Award

Dr. Priti Prasanna Maity | Tissue Engineering | Best Researcher Award

University of California, Riverside, India

Author Profile

🌱 Early Academic Pursuits

Dr. Maity’s academic journey began with an M.Sc. in Medical Laboratory Technology at Vidyasagar University (2004–2006), where her thesis on lipid profiling in chronic smokers laid the foundation for her interest in the health sciences. She then pursued a Master’s in Medical Science & Technology at the prestigious Indian Institute of Technology, Kharagpur (IIT-Kgp), where she conducted groundbreaking research on the molecular and structural profiling of phyllodes tumors and fibroadenomas. Her research offered new insights into diagnostic markers, enhancing the understanding of these conditions and paving the way for more effective diagnostics in clinical settings. This early foundation established Dr. Maity’s commitment to bridging scientific inquiry with practical medical applications.

🧪 Professional Endeavors

Dr. Maity’s professional trajectory showcases an impressive range of positions at reputable institutions. Her PhD at the Indian Institute of Engineering Science and Technology (IIEST, Shibpur) focused on cartilage tissue engineering, a project that not only highlighted her expertise in biomaterials but also her innovative approach to utilizing bio-waste for medical applications. Specifically, she explored the potential of capra ear cartilage in creating micro-tissue particles and injectable hydrogels to promote cartilage regeneration. This work, which included testing on animal models, underscored her potential as a leader in regenerative medicine and garnered significant attention within the research community.After completing her PhD, Dr. Maity embarked on a series of postdoctoral research associate roles in the United States. At the University of California, San Diego, her work on the gut microbiome led to notable breakthroughs in probiotic research. By developing patient-derived colon organoids, she assessed the impact of probiotics on gut barrier integrity, demonstrating their potential in enhancing gut health and treating Crohn’s Disease subtypes. Her work has shown that probiotics and postbiotics could significantly improve the integrity of gut models, specifically aiding non-stricturing, non-penetrating Crohn’s Disease, offering new hope for treatment-resistant patients.Following her work in San Diego, Dr. Maity joined the Medical University of South Carolina as a postdoctoral research associate, where she advanced her expertise in cancer research by generating colon organoids. Her work involved drug resistance assays on CRC cell lines and cutting-edge techniques such as immunofluorescence, qPCR, confocal microscopy, and flow cytometry, equipping her with a comprehensive skill set in molecular biology. Currently, Dr. Maity holds a postdoctoral position at the University of California, Riverside, where she is working on developing co-culture methods in a Gut-on-a-chip system, a project that merges tissue engineering and microbiology in novel ways.

🔬 Contributions and Research Focus

Dr. Maity’s research contributions have consistently targeted high-impact areas in biomedical sciences. Her work on cartilage tissue engineering and bio-waste-derived biomaterials promises a sustainable alternative to synthetic materials in regenerative medicine. Her development of patient-derived organoids has provided valuable models for studying gut health and the therapeutic potential of probiotics. Additionally, her research in cancer biology—particularly her work on drug-resistant colon cancer cell lines—highlights her dedication to addressing critical challenges in oncology.Her collaboration on gut health models, where she investigated the influence of probiotics and postbiotics on intestinal barrier function, has significant implications for gastrointestinal diseases. This pioneering work holds promise for developing treatments that target specific disease subtypes, offering individualized approaches to managing conditions such as Crohn’s disease.

🏆 Accolades and Recognition

Dr. Maity’s groundbreaking research and contributions to the fields of tissue engineering and microbiome science have been widely recognized. Throughout her career, her projects have attracted the attention of academic peers, and her findings have been presented in several prestigious journals and conferences. Moreover, her training in data science at MIT’s Schwarzman College of Computing has further bolstered her analytical capabilities, enabling her to integrate computational techniques into her research, an increasingly valuable skill in biomedical sciences.

🌍 Impact and Influence

Dr. Maity’s work has had a profound impact on both academic research and clinical applications. Her interdisciplinary approach has bridged the gap between laboratory research and potential therapeutic applications, especially in the fields of regenerative medicine, oncology, and gut health. Her tissue engineering research, for instance, has opened up new possibilities for sustainable bio-waste applications, while her insights into organoid modeling have influenced current practices in studying disease mechanisms and treatment responses.Her contributions are also a testament to the growing relevance of organ-on-a-chip systems, which are helping researchers study complex interactions in controlled environments. Her work on Gut-on-a-chip could revolutionize the study of intestinal health, offering models that accurately mimic human physiology and provide new insights into gastrointestinal conditions.

🌟 Legacy and Future Contributions

Dr. Maity’s work stands as a testament to her unwavering dedication to advancing biomedical research. Her innovative projects have not only furthered understanding in her field but have also inspired a new generation of scientists to pursue research that addresses global health challenges. As she continues to expand her research at the University of California, Riverside, she is likely to drive new developments in tissue engineering and microbiome science, with a focus on translating her findings into therapeutic applications.Looking forward, Dr. Maity is well-positioned to make impactful contributions in biomedical innovation. With her deep expertise in organoid technology, her ability to integrate data science into biological research, and her commitment to interdisciplinary collaboration, her future work promises to break new ground. She remains an influential figure in her field, with her research likely to inspire advancements in disease modeling, personalized medicine, and sustainable biomaterials in the years to come.

Citations

A total of 1395 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         1395
  • h-index           36
  • i10-index        21

Notable Publications 

  • A living organoid biobank of patients with Crohn’s disease reveals molecular subtypes for personalized therapeutics
    Authors: Tindle, C., Fonseca, A.G., Taheri, S., Das, S., Ghosh, P.
    Journal: Cell Reports Medicine
    Year: 2024.
  • Peptide-Based Biomaterials for Bone and Cartilage Regeneration
    Authors: Kapat, K., Kumbhakarn, S., Sable, R., Takle, S., Maity, P.
    Journal: Biomedicines
    Year: 2024.
  • Recent Advances and Challenges in the Early Diagnosis and Treatment of Preterm Labor
    Authors: Gondane, P., Kumbhakarn, S., Maity, P., Kapat, K.
    Journal: Bioengineering
    Year: 2024.
  • Development of functional resident macrophages in human pluripotent stem cell-derived colonic organoids and human fetal colon
    Authors: MĂşnera, J.O., Kechele, D.O., Bouffi, C., Helmrath, M.A., Wells, J.M.
    Journal: Cell Stem Cell
    Year: 2023.
  • Editorial: Fluorescent nanomaterials for biomedical applications
    Authors: Ganguly, S., Das, P., Parameswaranpillai, J., Maity, P.P.
    Journal: Frontiers in Materials
    Year: 2023.

Nethaji Muniraj | Cell therapy | Best Research Award

Dr. Nethaji Muniraj | Cell therapy | Best Research Award

Children’s National Hospital, Washington DC, India

Author Profile

Early Academic Pursuits 🎓

Nethaji Muniraj’s academic journey showcases a deep-rooted passion for biochemistry and molecular medicine. He began his higher education in India, earning a Bachelor of Science in Biochemistry from the University of Madras between 1996 and 1999. His undergraduate studies provided him with a solid foundation in subjects like bio-organic chemistry, intermediary metabolism, analytical methods, physiology, and clinical biochemistry. This early focus on understanding the biochemical processes within living organisms set the stage for his later work in molecular medicine and cancer research.Driven by his thirst for knowledge and a commitment to advancing medical science, Muniraj pursued a Master of Science in Medical Biochemistry at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) under Pondicherry University from 1999 to 2002. His coursework spanned diverse subjects such as human anatomy, physiology, cell and molecular biology, endocrinology, and clinical biochemistry. These early academic years equipped him with a comprehensive understanding of the intricate biochemical processes underlying human health and disease.Building on his strong academic foundation, Muniraj embarked on his most significant academic achievement — a PhD in Molecular Medicine from the prestigious Liggins Institute at the University of Auckland, New Zealand (2007-2012). His PhD thesis, titled Molecular Characterization of Trefoil Factor 1 (TFF1) in Gastric Carcinoma Cells, highlighted his emerging expertise in cancer biology. The research involved identifying molecular mechanisms in gastric carcinoma, contributing to the growing field of cancer therapeutics. This pivotal phase of his academic career cemented his future direction in cancer research and molecular medicine.

Professional Endeavors 🌍

Nethaji Muniraj’s professional career has been a global journey across continents, underscoring his determination to apply his expertise to various challenging roles. His work experience began in India as a Junior Research Fellow at Shriram Institute for Industrial Research, Bangalore (2002-2005), where he focused on applied biochemical research. He further deepened his research experience by serving as a Junior Research Fellow at the National Institute of Animal Nutrition and Physiology (NIANP), Bangalore from 2012 to 2013. During this period, Muniraj gained invaluable experience in research methodologies, laboratory techniques, and data analysis, enhancing his ability to conduct cutting-edge scientific research.His international research career took off with a series of prestigious positions in New Zealand. Muniraj worked as an Assistant Research Fellow at the University of Otago, first in the Department of Pathology (2013-2014) and then in the Department of Microbiology & Immunology (2014). These roles allowed him to explore various immunological and pathological aspects of diseases, particularly focusing on cancer.Muniraj’s journey reached a significant milestone when he joined the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, USA, in 2014 as a Postdoctoral Research Fellow. Over the next seven years (2014-2021), he delved deeper into oncology research, investigating novel cancer treatments and contributing to the fight against this devastating disease. His research at one of the world’s most renowned cancer centers solidified his standing as a leading figure in cancer immunology and therapeutic research.Currently, Muniraj holds the position of Staff Scientist-I at Children’s National Hospital’s Center for Cancer and Immunology Research (CCIR), Washington, DC, USA, where he continues his groundbreaking work in cancer immunology, focusing on translational research to develop therapies for childhood cancers.

Contributions and Research Focus 🔬

Nethaji Muniraj’s research focus has been deeply intertwined with cancer biology and immunology, particularly in the context of developing novel therapeutic approaches. His PhD thesis on Trefoil Factor 1 (TFF1) in gastric carcinoma cells contributed to a better understanding of how TFF1, a protein involved in mucosal protection, plays a role in cancer progression. This work helped pave the way for future research into the mechanisms underlying gastric cancer, an area of significant global health concern.At Johns Hopkins University, Muniraj expanded his research to explore oncology, working on various cancer models and understanding the molecular mechanisms that contribute to tumor development, growth, and metastasis. His research in cancer immunology aimed to harness the body’s immune system to combat cancer, leading to potential advances in immunotherapy treatments. His contributions in this field are aligned with the broader movement towards more personalized and effective cancer therapies.Muniraj’s current work at Children’s National Hospital continues this trajectory, with a focus on pediatric cancers. His research integrates molecular biology, immunology, and clinical science, striving to develop more targeted therapies for young patients with cancer. This cutting-edge research aims to revolutionize cancer treatment by minimizing side effects and improving survival rates among children.

Accolades and Recognition 🏆

Throughout his illustrious career, Nethaji Muniraj has garnered significant recognition for his contributions to molecular medicine and cancer research. His PhD work at the University of Auckland earned him accolades within the academic community, and his subsequent positions at prestigious institutions such as Johns Hopkins University and Children’s National Hospital speak volumes about his reputation in the field.In addition to his professional roles, Muniraj has contributed to numerous peer-reviewed journals, further enhancing his reputation as an authority in cancer research. His collaborative work across the globe, particularly in the fields of immunology and oncology, has placed him among the influential voices in translational cancer research.

Impact and Influence 🌟

Nethaji Muniraj’s research has had a far-reaching impact, particularly in the realm of cancer treatment and immunotherapy. His contributions to understanding the molecular mechanisms of cancer and the role of the immune system in combating the disease have opened new avenues for therapeutic interventions. Muniraj’s work has influenced both his peers and future generations of researchers, contributing to the global effort to develop more effective cancer treatments.His role as a mentor and researcher has also helped shape the next generation of scientists, guiding them towards impactful careers in biochemistry, molecular medicine, and cancer research. His presence in leading cancer research institutions such as Johns Hopkins and Children’s National Hospital underscores his influential role in shaping the future of cancer therapy.

Legacy and Future Contributions 🌍✨

Nethaji Muniraj’s legacy lies in his tireless dedication to advancing cancer research, particularly in the realm of immunotherapy and molecular medicine. His work continues to inspire new research directions, particularly in the fight against pediatric cancers. With his continued efforts at Children’s National Hospital, Muniraj is poised to make even greater contributions to science, offering hope to countless individuals affected by cancer worldwide.Looking ahead, Muniraj’s future contributions will likely focus on further refining immunotherapy techniques and translating molecular research into clinical applications. His legacy will be one of innovation, perseverance, and dedication to improving human health through scientific discovery.

Citations

A total of 1036 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         1036
  • h-index           16
  • i10-index        18

Notable Publications 

  • Title: ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
    Authors: SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj, P Kuppusamy, …
    Journal: Autophagy, Volume 13, Issue 8, Pages 1386-1403
    Year: 2017.
  • Title: A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes
    Authors: S Parida, S Wu, S Siddharth, G Wang, N Muniraj, A Nagalingam, C Hum, …
    Journal: Cancer Discovery, Volume 11, Issue 5, Pages 1138-1157
    Year: 2021.
  • Title: Regulation of chemokines and cytokines by histone deacetylases and an update on histone deacetylase inhibitors in human diseases
    Authors: HR Gatla, N Muniraj, P Thevkar, S Yavvari, S Sukhavasi, MR Makena
    Journal: International Journal of Molecular Sciences, Volume 20, Issue 5, Article 1110
    Year: 2019.
  • Title: Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
    Authors: S Sengupta, A Nagalingam, N Muniraj, MY Bonner, P Mistriotis, A Afthinos, …
    Journal: Oncogene, Volume 36, Issue 41, Pages 5709-5721
    Year: 2017.
  • Title: Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells
    Authors: N Amiry, X Kong, N Muniraj, N Kannan, PM Grandison, J Lin, Y Yang, …
    Journal: Endocrinology, Volume 150, Issue 10, Pages 4473-4483
    Year: 2009.